{
    "organizations": [],
    "uuid": "38dcc983b8e1215a934510122719c6d520838d29",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amicus-therapeutics-announces-publ/brief-amicus-therapeutics-announces-public-offering-of-common-stock-idUSASB0C5R3",
    "ord_in_thread": 0,
    "title": "BRIEF-Amicus Therapeutics Announces Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 14, 2018 / 9:27 PM / in 10 minutes BRIEF-Amicus Therapeutics Announces Public Offering Of Common Stock Reuters Staff Feb 14 (Reuters) - Amicus Therapeutics Inc: * AMICUS THERAPEUTICS ANNOUNCES PUBLIC OFFERING OF COMMON STOCK * AMICUS THERAPEUTICS INC - COMMENCED A $250 MILLION UNDERWRITTEN PUBLIC OFFERING OF ITS COMMON STOCK * AMICUS THERAPEUTICS INC - EXPECTS TO USE NET PROCEEDS OF OFFERING FOR INVESTMENT IN U.S., INTERNATIONAL COMMERCIAL INFRASTRUCTURE FOR MIGALASTAT HCL * AMICUS THERAPEUTICS INC - TO ALSO USE NET PROCEEDS OF OFFERING FOR INVESTMENT IN MANUFACTURING CAPABILITIES FOR ATB200, AMONG OTHERS Source text for Eikon: Further company coverage:",
    "published": "2018-02-14T23:25:00.000+02:00",
    "crawled": "2018-02-14T23:40:55.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "therapeutic",
        "announces",
        "public",
        "offering",
        "common",
        "stock",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "amicus",
        "therapeutic",
        "inc",
        "amicus",
        "therapeutic",
        "announces",
        "public",
        "offering",
        "common",
        "stock",
        "amicus",
        "therapeutic",
        "inc",
        "commenced",
        "million",
        "underwritten",
        "public",
        "offering",
        "common",
        "stock",
        "amicus",
        "therapeutic",
        "inc",
        "expects",
        "use",
        "net",
        "proceeds",
        "offering",
        "investment",
        "international",
        "commercial",
        "infrastructure",
        "migalastat",
        "hcl",
        "amicus",
        "therapeutic",
        "inc",
        "also",
        "use",
        "net",
        "proceeds",
        "offering",
        "investment",
        "manufacturing",
        "capability",
        "atb200",
        "among",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}